WHO引导的数字健康干预对黎巴嫩叙利亚难民抑郁效果:随机对照试验
在黎巴嫩开展的单盲、两臂实用性随机临床试验,纳入569名PHQ-9≥10且WHODAS>16的叙利亚流离失所者,比较引导式Step-by-Step与强化常规照护(ECAU)。意向性分析显示干预在抑郁、功能受损、创伤后应激、焦虑、主观幸福感和自述问题方面均有显著效果(SMD 0.35–0.49),3个月随访维持;主要局限为高失访率。
要点
- 引导式Step-by-Step在改善抑郁(SMD 0.48)和功能受损(SMD 0.35)方面优于ECAU。
- 创伤后应激、焦虑、主观幸福感和自述问题也均显著改善(SMD 0.36–0.49)。
- 所有效果在3个月随访时维持;试验期间发生1例与干预无关的严重不良事件。
核心结论
- 引导式数字干预能有效减轻黎巴嫩流离失所者的抑郁,应提供给有数字接入的流离失所社区。
研究设计与样本
- 单盲、两臂实用性随机临床试验,比较引导式Step-by-Step与强化常规照护(ECAU)。
- 共569名来自叙利亚的流离失所者,伴抑郁(PHQ-9≥10)和功能受损(WHODAS>16),随机分入Step-by-Step组(N=283,失访167)或ECAU组(N=286,失访133)。
- 招募自2019年12月9日开始至2020年7月9日完成,末次随访评估于2020年12月收集。
- 研究团队可访问在线平台查看每名参与者的治疗分组,所有问卷由参与者在线完成。
主要发现
- 意向性分析显示干预对抑郁有显著效果(SMD 0.48;95%CI 0.26–0.70;p<0.001)。
- 对功能受损有显著效果(SMD 0.35;95%CI 0.14–0.56;p<0.001)。
- 对创伤后应激有显著效果(SMD 0.36;95%CI 0.16–0.56;p<0.001),对焦虑有显著效果(SMD 0.46;95%CI 0.24–0.68;p<0.001)。
- 对主观幸福感有显著效果(SMD 0.47;95%CI 0.26–0.68;p<0.001),对自述个人问题有显著效果(SMD 0.49;95%CI 0.28–0.70;p<0.001)。
- 所有结局的显著效果在3个月随访时维持;试验期间发生1例与干预无关的严重不良事件。
临床怎么用
- 作者认为所检验的引导式WHO Step-by-Step干预应提供给有数字接入的流离失所社区。
局限性
- 当前试验的主要局限是高失访率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most displaced people with mental disorders in low- and middle-income countries do not receive effective care, and their access to care has deteriorated during the Coronavirus Disease 2019 (COVID-19) pandemic. Digital mental health interventions are scalable when digital access is adequate, and they can be safely delivered during the COVID-19 pandemic. We examined whether a new WHO-guided digital mental health intervention, Step-by-Step, in which participants were supported by a nonspecialist helper, was effective in reducing depression among displaced people in Lebanon. METHODS AND FINDINGS: We conducted a single-blind, 2-arm pragmatic randomized clinical trial, comparing guided Step-by-Step with enhanced care as usual (ECAU) among displaced Syrians suffering from depression and impaired functioning in Lebanon. Primary outcomes were depression (Patient Health Questionnaire, PHQ-9) and impaired functioning (WHO Disability Assessment Schedule-12, WHODAS) at posttreatment. Secondary outcomes included subjective well-being, anxiety, post-traumatic stress, and self-described problems. A total of 569 displaced people from Syria with depression (PHQ-9 ≥ 10) and impaired functioning (WHODAS > 16) were randomized to Step-by-Step (N = 283; lost to follow-up: N = 167) or ECAU (N = 286; lost to follow-up: 133). Participants were considered to be lost to follow-up when they did not fill in the outcome measures at posttest or follow-up. Recruitment started on December 9, 2019 and was completed on July 9, 2020. The last follow-up assessments were collected in December 2020. The study team had access to the online platform, where they could see treatment arm assignment for each participant. All questionnaires were completed by participants online. Intention-to-treat (ITT) analyses showed intervention effects on depression (standardized mean differences [SMDs]: 0.48; 95% CI: 0.26; 0.70; p < 0.001), impaired functioning (SMD: 0.35; 95% CI: 0.14; 0.56; p < 0.001), post-traumatic stress (SMD: 0.36; 95% CI: 0.16; 0.56; p < 0.001), anxiety (SMD: 0.46; 95% CI: 0.24; 0.68; p < 0.001), subjective well-being (SMD: 0.47; 95% CI: 0.26; 0.68; p < 0.001), and self-identified personal problems (SMD: 0.49; 95% CI 0.28; 0.70; p < 0.001). Significant effects on all outcomes were maintained at 3 months follow-up. During the trial, one serious adverse event occurred, unrelated to the intervention. The main limitation of the current trial is the high dropout rate. CONCLUSIONS: In this study, we found that a guided, digital intervention was effective in reducing depression in displaced people in Lebanon. The guided WHO Step-by-Step intervention we examined should be made available to communities of displaced people that have digital access. TRIAL REGISTRATION: ClinicalTrials.gov NCT03720769.
引用
- Cuijpers P, Heim E, Abi Ramia J, et al. Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial. PLoS Med. 2022. PMID: 35737665. doi:10.1371/journal.pmed.1004025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。